drugset / Trial / NCT00398619

A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

NCT00398619 ↗

Phase 1 Completed Incyte Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.

Timeline

Start
2006-11
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB13739 Unknown — —

Indications